Exclusive | EU Confirms End of Tobacco Policy Expert Group, Explores New Cooperation Structures as TPD Revision Continues

Jan.22
Exclusive | EU Confirms End of Tobacco Policy Expert Group, Explores New Cooperation Structures as TPD Revision Continues
2Firsts reporting shows that, as the European Union moves toward a future evaluation of its tobacco legislation, the Tobacco Policy Expert Group—long a key platform for coordination among Member States—formally concluded its mandate at the end of 2025. At the same time, the European Commission is exploring new cooperation structures to address the resulting institutional gap.

Key Points

 

  • The EU’s Tobacco Policy Expert Group formally concluded its mandate at the end of 2025, with successor arrangements yet to be clarified.
  • The European Commission has confirmed that the evaluation of tobacco legislation is ongoing and that plans for a future revision remain on track.
  • Pending new structures, coordination among Member States continues through existing channels, including the JA-SAFE mechanism.

 


 

2Firsts, January 22, 2026, Brussels —

 

The European Union’s tobacco and nicotine regulatory framework is entering a period of institutional transition, as a long-standing expert advisory body concludes its mandate while the European Commission continues evaluating future legislative changes.

 

A review of publicly available European Commission documents by 2Firsts shows that the Group of Experts on Tobacco Policy (E03150) held its final meeting on October 28, 2025, in Luxembourg. The meeting minutes, published on the Commission’s expert group register on January 5, 2026, confirm that it was the last session under the group’s current mandate.

 

Exclusive | EU Confirms End of Tobacco Policy Expert Group, Explores New Cooperation Structures as TPD Revision Continues
Minutes of the final meeting of the EU Group of Experts on Tobacco Policy (28 October 2025, Luxembourg).| Source: European Commission, DG SANTE (Ref. Ares(2026)28575)

 

Established in 2014 under Commission Decision C(2014) 3509, the expert group served as a formal forum for cooperation and information exchange between the Commission and Member States on tobacco control. Its remit included supporting the preparation and implementation of EU tobacco legislation, including delegated acts under the Tobacco Products Directive (TPD).

 

Although the group continues to appear as “active” in the Commission’s register, its legal basis expired at the end of 2025. According to the October meeting minutes, no further meetings were scheduled, and no successor expert group has so far been publicly announced.

 

Transition after the expert group

 

According to the meeting minutes, the Commission is exploring future structures for cooperation and information exchange with Member States following the conclusion of the expert group’s mandate. At the same time, engagement with national authorities on tobacco and nicotine control is continuing through existing, file-specific channels.

 

The approach points to an effort to preserve policy continuity while reassessing how technical coordination and consultation are organised at EU level, particularly as regulatory debates around novel tobacco and nicotine products continue to evolve.

 

TPD evaluation remains underway

 

The end of the expert group does not signal a pause in EU tobacco legislation. The October meeting minutes show that the Commission continues to carry out a comprehensive evaluation of both the Tobacco Products Directive (Directive 2014/40/EU) and the Tobacco Advertising Directive, with Member States encouraged to submit data, experience and feedback to inform the process.

 

Commission documentation further shows that the Commission intends to bring forward a revision of the legislative framework on tobacco control once the evaluation phase is completed. No formal proposal has yet been tabled, and no official timeline has been confirmed.

 

The ongoing work on tobacco regulation has been linked to broader public health initiatives. At the October meeting, the chair referred to the EU Cardiovascular Health Plan, highlighting the close relationship between tobacco use and cardiovascular disease prevention.

 

Cardiovascular Health Plan draws attention

 

As previously reported by 2Firsts in September 2025, the European Commission’s public consultation on the EU Cardiovascular Health Plan — a non-legislative Commission Communication led by DG SANTE — had already drawn attention from stakeholders concerned about how cardiovascular prevention narratives might influence future tobacco legislation.

 

Although the consultation documents do not explicitly mention nicotine, stakeholder submissions revealed a clear divide. Harm reduction advocates called for evidence-based, risk-proportionate regulation recognising the lower risks of non-combustible products, while restriction-focused organisations urged stricter controls, including flavour bans and the equal treatment of all nicotine products.

 

The plan, which the Commission had previously indicated was targeting adoption in late 2025, continues to be closely watched, as any references to prevention and unhealthy behaviours could later be cited in debates surrounding a future revision of the TPD.

 

Role of JA-SAFE and internal responsibilities

 

Alongside legislative evaluation, the Commission continues to advance implementation-focused initiatives. One such project is JA-SAFE — the Joint Action on Health Promotion and Disease Prevention, including Smoke- and Aerosol-Free Environments — which was presented to Member States at the October meeting.

 

JA-SAFE is designed to support the implementation of the Council Recommendation on smoke-free and aerosol-free environments, primarily through cooperation, pilot activities, data sharing and the dissemination of best practices. It functions as a complementary, execution-oriented framework rather than a policy-shaping or legislative body.

 

Within the Commission, responsibility for tobacco control remains assigned to Directorate C of the Directorate-General for Health and Food Safety (DG SANTE), in line with established internal governance arrangements. The allocation reflects administrative organisation rather than a shift in policy direction.

 

A period of adjustment

 

Taken together, the publicly available documents suggest that EU tobacco and nicotine policy is entering a transitional phase. The conclusion of the expert group closes a formal chapter in Member State coordination, while evaluation work and preparatory steps for possible legislative revision continue within the Commission.

 

How future cooperation structures will be designed — and how they will interact with broader public health strategies such as the Cardiovascular Health Plan — remains to be seen. What is clear is that the regulatory debate over tobacco harm reduction, novel products and risk-differentiated policy is far from settled.

 

For further updates on European tobacco and nicotine regulatory developments, stay tuned to 2Firsts’ ongoing coverage.

 

Cover image:The European Quarter in Brussels.| Source: Photo by 2Firsts


 

Further reading:

 

2FIRSTS | Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
2FIRSTS | Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
The EU’s consultation on the Cardiovascular Health Plan, though not mentioning nicotine, has sparked debate over novel tobacco regulation. Advocates urge evidence-based recognition of harm reduction products, while opponents call for tighter rules. The plan may influence TPD III, drawing close scrutiny from both industry and health groups.
www.2firsts.com

2FIRSTS | Special Report | Battle Over Flavors: Spain’s flavor and pouch curbs spark Brussels showdown over the single market
2FIRSTS | Special Report | Battle Over Flavors: Spain’s flavor and pouch curbs spark Brussels showdown over the single market
Spain’s proposed ban on non-tobacco vape flavors and strict cap on nicotine pouches has evolved from a domestic tobacco control measure into a major dispute at the EU level. This report traces the full trajectory of the controversy—covering policy background, EU review, stakeholder positions, and potential impacts—showing how the debate has moved beyond tobacco control to challenge the fundamental freedoms of the EU single market.
www.2firsts.com

Virginia HB 308 would overhaul tobacco and nicotine rules, and creating a vape “white list”
Virginia HB 308 would overhaul tobacco and nicotine rules, and creating a vape “white list”
Virginia’s HB 308 (Substitute) proposes a sweeping rewrite of how tobacco, nicotine and certain smokable hemp products are regulated, consolidating enforcement under ABC, requiring retailer permits, creating a vape product directory and escalating penalties for violations.
Feb.06 by 2FIRSTS.ai
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA announced it will convene a Feb. 10, 2026 roundtable with small tobacco product manufacturers to gather feedback on PMTA submissions for ENDS products. The discussion will be viewable online, and a public docket is open for comments through March 12, 2026.
Feb.10 by 2FIRSTS.ai
UK vape firm Plxsur sold for £76,500 after touting $1 billion revenue target
UK vape firm Plxsur sold for £76,500 after touting $1 billion revenue target
London-based vaping company Plxsur, which had claimed in fundraising materials it could reach $1 billion in annual revenue and capture about 10% of the global vaping market, has been sold out of administration for £76,500. Administrators said the figures were aspirational and depended on acquisitions that were never completed, as the company later ran out of cash and entered insolvency, with a shareholder ultimately buying the business.
Jan.22 by 2FIRSTS.ai
California federal judge certifies direct purchaser class in Juul–Altria antitrust litigation
California federal judge certifies direct purchaser class in Juul–Altria antitrust litigation
A California federal judge has certified a class of direct purchasers of Juul products in antitrust litigation alleging Juul and Altria conspired to have Altria exit the e-cigarette market.
Mar.02 by 2FIRSTS.ai
Spain’s Galicia Moves First: Under-18 Vape and Energy Drink Sales and Use Banned
Spain’s Galicia Moves First: Under-18 Vape and Energy Drink Sales and Use Banned
Galicia will implement a new “Minor Health Protection and Addictive Behaviors Prevention” law this Saturday, becoming the first region in Spain to ban the sale and use of vapes for people under 18.
Mar.09 by 2FIRSTS.ai
PMI Launches Mass Production of ZYN at $600M Aurora Manufacturing Hub
PMI Launches Mass Production of ZYN at $600M Aurora Manufacturing Hub
Philip Morris International (PMI), through its subsidiary Swedish Match, has started large-scale production at a 600,000-square-foot ZYN nicotine pouch facility in Aurora, Colorado. The $600 million investment makes the site one of three ZYN manufacturing plants in the United States and the company’s second U.S. facility after Owensboro, Kentucky.
PMI
Feb.21